RARE ALERT: GlaxoSmithKline said to ... - Part 5
The European-based investor group seeking to persuade the board of Aurinia Pharmaceuticals to carry out a strategic review has appointed a US lawyer to manage an action group for other investors looking to back its activist campaign.
The move comes as the investment consortium, led by the Switzerland-based MKT Tactical Fund, recently wrote a second letter to the chairman of Aurinia, George Milne Junior...
Register
Register for free to see rest of this article and all public articles from Betaville
Login / RegisterDate: Tuesday, 22 March 2022, 4:24 pm